Matrix Gla protein maintains normal and malignant hematopoietic progenitor cells by interacting with bone morphogenetic protein-4
| Autor: | Akio Maekawa, Chie Goto, Kana Kuronuma, Mai Tsuruta, Haruka Murata, Tomoya Fukuoka, Muneaki Miyata, Aya Yokoi, Hikari Okamoto, Satowa Tanaka, Miki Matsuo, Hao-Wei Han, Mitsuhiro Ito, Leo Matsubara, Shigetaka Asano, Natsumi Hasegawa |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Cell biology Stromal cell Molecular biology Physiology Hematopoietic niche Cancer research Molecular dynamics Bone morphogenetic protein Biochemistry Article 03 medical and health sciences 0302 clinical medicine BMP-2 Matrix gla protein medicine lcsh:Social sciences (General) lcsh:Science (General) Biomolecules Multidisciplinary biology Chemistry Mesenchymal stem cell nutritional and metabolic diseases Bone morphogenetic protein-4 (BMP-4) Mediator transcriptional coregulatory complex Matrix Gla protein (MGP) Haematopoiesis Stem cells research 030104 developmental biology medicine.anatomical_structure Oncology Bone morphogenetic protein 4 Hematological system biology.protein lcsh:H1-99 Myelopoiesis Bone marrow 030217 neurology & neurosurgery lcsh:Q1-390 |
| Zdroj: | Heliyon, Vol 6, Iss 4, Pp e03743-(2020) Heliyon |
| ISSN: | 2405-8440 |
| DOI: | 10.1016/j.heliyon.2020.e03743 |
| Popis: | Matrix Gla protein (MGP), a modulator of the BMP-SMAD signals, inhibits arterial calcification in a Glu γ-carboxylation dependent manner but the role of MGP highly expressed in a subset of bone marrow (BM) mesenchymal stem/stromal cells is unknown. Here we provide evidence that MGP might be a niche factor for both normal and malignant myelopoiesis. When mouse BM hematopoietic cells were cocultured with mitomycin C-treated BM stromal cells in the presence of anti-MGP antibody, growth of hematopoietic cells was reduced by half, and maintenance of long-term culture-initiating cells (LTC-ICs) was profoundly attenuated. Antibody-mediated blockage of MGP also inhibited growth (by a fifth) and cobblestone formation (by half) of stroma-dependent MB-1 myeloblastoma cells. MGP was undetectable in normal hematopoietic cells but was expressed in various mesenchymal cells and was aberrantly high in MB-1 cells. MGP and bone morphogenetic protein (BMP)-4 were co-induced in stromal cells cocultured with both normal hematopoietic cells and MB-1 myeloblastoma cells in an oscillating several days-periodic manner. BMP-2 was also induced in stromal cells cocultured with normal hematopoietic cells but was barely expressed when cocultured with MB-1 cells. GST-pulldown and luciferase reporter assays showed that uncarboxylated MGP interacted with BMP-4 and that anti-MGP antibody abolished this interaction. LDN-193189, a selective BMP signaling inhibitor, inhibited growth and cobblestone formation of MB-1 cells. The addition of warfarin, a selective inhibitor of vitamin K-dependent Glu γ-carboxylation, did not affect MB-1 cell growth, suggesting that uncarboxylated MGP has a biological effect in niche. These results indicate that MGP may maintain normal and malignant hematopoietic progenitor cells, possibly by modulating BMP signals independently of Glu γ-carboxylation. Aberrant MGP by leukemic cells and selective induction of BMP-4 relative to BMP-2 in stromal cells might specify malignant niche. Biochemistry; Cancer research; Cell biology; Molecular biology; Physiology; Stem cells research; Biomolecules; Molecular dynamics; Hematological system; Oncology; Matrix Gla protein (MGP), Bone morphogenetic protein-4 (BMP-4), BMP-2, Hematopoietic niche, Mediator transcriptional coregulatory complex. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|